A carregar...
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea
Carcinoid syndrome (CS), characterized by diarrhea and flushing, is present in 20% of patients with neuroendocrine tumors at diagnosis and becomes more frequent with progression. The diarrhea of CS is caused mainly by tumoral secretion of serotonin. It may not be fully controlled by somatostatin ana...
Na minha lista:
| Publicado no: | Future Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734517/ https://ncbi.nlm.nih.gov/pubmed/29350062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2017-0340 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|